Connect with us
MARE BALTICUM Gaming & TECH Summit 2024

Fintech PR

Data-Driven Financial Decisions Drive Financial Analytics Market to US$ 25.2 Billion by 2033 | Future Market Insights, Inc.

Published

on

data-driven-financial-decisions-drive-financial-analytics-market-to-us$-252-billion-by-2033-|-future-market-insights,-inc.

The financial analytics market is poised for strong growth in the coming years, driven by businesses’ increasing focus on data-driven decision-making. This trend is powerful in Asia, where the banking and insurance sectors are increasingly interested in financial analytics. Cloud-based financial analytics solutions are also gaining traction in the market, as they offer businesses a more affordable and scalable way to implement financial analytics solutions.

NEWARK, Del., Oct. 25, 2023 /PRNewswire/ — Financial Analytics Market Analysis by Database Management System and Data Integration Tool, Growth Opportunities and Revenue Forecast 2023 – 2033

The market size of financial analytics is tipped to be US$ 8,462.6 million in 2023. In 2022, the market size was US$ 7,700.3 million. The market’s future is bright as the CAGR from 2023 to 2033 is forecasted to be 11.5%. By 2033, the size of the market is predicted to have jumped to US$ 25,208.4 million.

Get the Sample PDF Summary to obtain an overview of the Comprehensive Research Report. The sample is available here!

A consequence of the business sector growth is the enlarged amounts of data businesses have to deal with. In-house systems for processing the data often turn out inadequate. Thus, businesses turn to financial analytics to handle big data. Financial analytics companies offer platforms that allow businesses to store, retrieve, and analyze data.

Businesses are seeking the help of financial analytics in decision-making. Enterprises seek smart solutions that take into consideration various aspects before making decisions. Companies are working to make smart decisions in financial matters as well, and financial analytics are aiding the decisions.

The scope of financial analytics is no longer limited to just businesses. Though businesses make up an overwhelming amount of customers, financial analytics are also provided to consumers. Financial analytics companies have started offering platforms that are open to consumers.

 “Cloud computing and AI-use are set to transform the capabilities of financial analytics. Cloud computing offers ample space for companies’ data, allowing for storage and processing in large numbers. An increasing number of new financial analytics platforms have started incorporating AI. There is thus a large amount of potential for financial analytics platforms that use cloud computing and AI,” says Sudip Saha is the managing director and co-founder at Future Market Insights.

Key Takeaways from the Financial Analytics Market

  • The financial analytics market is expected to reach a valuation of US$ 8,462.6 million in 2023.
  • Database Management Systems (DBMS) are the most common type of financial analytics in demand. For 2023, database management systems are expected to hold 18.4% of the market share by type.
  • Financial analytics are most often used for assets and liabilities. In 2023, assets and liabilities are expected to contribute 20.5% of the market share by application.
  • The market is expected to grow rapidly in India. The CAGR for the Indian market during the 2023 to 2033 period is projected to be a stunning 18.5%.
  • China is a lucrative region for the market and is expected to continue to progress at a good pace. The CAGR for China is tipped to be 15.2% for the forecast period.
  • Japan and South Korea are other Asian countries where the market is expected to flourish. The CAGR for South Korea and Japan is projected to be 12.2% and 14.3% respectively over the forecast period.

Country-wise Analysis: Financial Analytics Market 2023 – 2033

Countries

CAGR (2023 to 2033)

United States Financial Analytics Market Size

6.3 %

India Financial Analytics Market Size

18.5 %

South Korea Financial Analytics Market

12.2 %

Japan Financial Analytics Market

14.3 %

Financial Analytics Market Size in China

15.2 %

 

Order Now: PESTLE and Porter’s Analysis to Help You Make Smart Financial Decisions in the Financial Analytics Market.

Competition Analysis of the Financial Analytics Market

The market is open for a variety of players, though a few established players have earned reputable names. Technology is set to play an important role in the financial analysis market. Some of the prominent companies in the market include SAP A.G., International Business Machines Corporation (IBM), Oracle Corporation, and TIBCO Software Inc. 

Recent Developments in the Financial Analytics Market

  • In July 2023, Bunker secured prominent funding. The Singapore-based player has ambitions to expand and improve its platform.
  • In May 2023, IBM watsonx.data was launched. The product from industry giant IBM is an open platform that integrates AI.
  • In June 2022, FinanceGPT from the South African company Ipoxcap was launched. It is another platform that concentrates on AI solutions and is also available in African languages.

Comprehensive Research Methodology of Financial Analytics Market Available here!

About the Author:

Sudip Saha is the managing director and co-founder at Future Market Insights, an award-winning market research and consulting firm. Sudip is committed to shaping the market research industry with credible solutions and constantly makes a buzz in the media with his thought leadership. His vast experience in market research and project management across verticals in APAC, EMEA, and the Americas reflects his growth-oriented approach to clients. 

He is a strong believer and proponent of innovation-based solutions, emphasizing customized solutions to meet one client’s requirements at a time. His foresightedness and visionary approach recently got him recognized as the ‘Global Icon in Business Consulting’ at the ET Inspiring Leaders Awards 2022.

Explore FMI’s Extensive Coverage in the Technology Domain

  • The global clinical workflow solution market is estimated to reach US$10,352.1 million in 2023. Technology experts project a robust CAGR of 16.8% through 2033, with a forecasted valuation of US$49,056.3 million by 2033 for clinical workflow solution providers.
  • The public cloud application infrastructure services market is projected to be valued at US$3,570.70 million in 2023, expected to reach US$22,527.80 million by 2033. This market is anticipated to surge at a CAGR of 20.2% from 2023 to 2033.
  • The Morocco Data Center Facility Market was US$93.5 million in 2018. It is expected to reach US$124.6 million in 2023, with a Y-o-Y growth of 5.8% in 2022. Over the 2023-2033 projection period, the industry is expected to exhibit a 7.6% CAGR, reaching a total size of US$259.9 million by 2033.
  • The demand for micro-investing platforms in Australia is expected to reach US$854.2 million in 2023, with a projected 19.1% CAGR from 2023 to 2033, reaching a valuation of around US$4,885.0 million by 2033. Globally, the demand for micro-investing platforms was US$734.5 million in 2022.
  • Sales of electronic skin in Western Europe are expected to surge at a remarkable 27.2% CAGR through 2033. The demand for electronic skin in Western Europe is anticipated to be US$355.7 million in 2023, with the industry projected to achieve a valuation of US$1,125.9 million by 2033.

About Future Market Insights (FMI)

Future Market Insights (FMI) is a leading market intelligence and consulting service provider, serving clients in over 150 countries. FMI is headquartered in Dubai and has delivery centers in the United Kingdom, the United States, and India. FMI’s latest market research reports, and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us
Nandini Singh Sawlani   
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: [email protected]
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs | YouTube

Logo: https://mma.prnewswire.com/media/1197648/3531122/FMI_Logo.jpg

 

Cision View original content:https://www.prnewswire.co.uk/news-releases/data-driven-financial-decisions-drive-financial-analytics-market-to-us-25-2-billion-by-2033–future-market-insights-inc-301966775.html

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Fintech PR

Invitation to presentation of EQT AB’s Q1 Announcement 2024

Published

on

invitation-to-presentation-of-eqt-ab’s-q1-announcement-2024

STOCKHOLM, April 5, 2024 /PRNewswire/ — EQT AB’s Q1 Announcement 2024 will be published on Thursday 18 April 2024 at approximately 07:30 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session.

The presentation and a video link for the webcast will be available here from the time of the publication of the Q1 Announcement.

To participate by phone and ask questions during the Q&A, please register here in advance. Upon registration, you will receive your personal dial-in details.

The webcast can be followed live here and a recording will be available afterwards.

Information on EQT AB’s financial reporting

The EQT AB Group has a long-term business model founded on a promise to its fund investors to invest capital, drive value creation and create consistent attractive returns over a 5 to 10-year horizon. The Group’s financial model is primarily affected by the size of its fee-generating assets under management, the performance of the EQT funds and its ability to recruit and retain top talent.

The Group operates in a market driven by long-term trends and thus believes quarterly financial statements are less relevant for investors. However, in order to provide the market with relevant and suitable information about the Group’s development, EQT publishes quarterly announcements with key operating numbers that are relevant for the business performance (taking Nasdaq’s guidance note for preparing interim management statements into consideration). In addition, a half-year report and a year-end report including financial statements and further information relevant for investors is published. Finally, EQT also publishes an annual report including sustainability reporting.

Contact
Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
EQT Shareholder Relations, [email protected]

Rickard Buch, Head of Corporate Communications, +46 72 989 09 11
EQT Press Office, [email protected], +46 8 506 55 334

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/eqt/r/invitation-to-presentation-of-eqt-ab-s-q1-announcement-2024,c3956826

The following files are available for download:

https://mb.cision.com/Main/87/3956826/2712771.pdf

Invitation to presentation of EQT AB’s Q1 Announcement 2024

https://news.cision.com/eqt/i/eqt-ab-group,c3285895

EQT AB Group

 

View original content:https://www.prnewswire.co.uk/news-releases/invitation-to-presentation-of-eqt-abs-q1-announcement-2024-302109147.html

Continue Reading

Fintech PR

Kia presents roadmap to lead global electrification era through EVs, HEVs and PBVs

Published

on

kia-presents-roadmap-to-lead-global-electrification-era-through-evs,-hevs-and-pbvs
  • Kia drives forward transformation into ‘Sustainable Mobility Solutions Provider’
  • Roadmap enables Kia to proactively respond to uncertainties in mobility industry landscape, including changes in EV market
  • Company to expand EV line-up with more models; enhance HEV line-up to manage fluctuation in EV demand
    • Goal to sell 1.6 million EVs annually in 2030, introducing 15 models
    • PBV to play a key role in Kia’s growth, targeting 250,000 PBV sales annually by 2030 with PV5 and PV7 models
  • Kia to invest KRW 38 trillion by 2028, including KRW 15 trillion for future business
  • 2024 business guidance : KRW 101 tln in revenue with KRW 12 tln in operating profit; operating profit margin of 11.9% on sales of 3.2 million units globally
  • CEO reaffirms Kia’s commitment to ESG management

SEOUL, South Korea, April 5, 2024 /PRNewswire/ — Kia Corporation (Kia) today shared an update on its future strategies and financial targets at its CEO Investor Day in Seoul, Korea.

Based on its innovative achievements in the years since the announcement of mid-to-long-term business initiatives, Kia is focusing on updating its 2030 strategy announced last year and further strengthening its business strategy in response to uncertainties across the global mobility industry landscape.

During the event, Kia updated its mid-to-long-term business strategy with a focus on electrification, and its PBV business. Kia reiterated its 2030 annual sales target of 4.3 million units, including 1.6 million units of electric vehicles (EVs). The 2030 4.3 million annual sales target is 34.4 percent higher than the brand’s 2024 annual goal of 3.2 million units.

The company also plans to become a leading EV brand by selling a higher percentage of electrified models among its total sales, including hybrid electric vehicles (HEV), plug-in hybrid (PHEV), and battery EVs, projecting electrified model sales of 2.48 million units annually or 58 percent of Kia’s total sales in 2030.

“Following our successful brand relaunch in 2021, Kia is enhancing its global business strategy to further the establishment of an innovative EV line-up and accelerate the company’s transition to a sustainable mobility solutions provider,” said Ho Sung Song, President and CEO of Kia. “By responding effectively to changes in the mobility market and efficiently implementing mid-to-long-term strategies, Kia is strengthening its brand commitment to the wellbeing of customers, communities, the global society, and the environment.”

Photo – https://mma.prnewswire.com/media/2380039/Photo_1__2024_CEO_Investor_Day.jpg
PDF – https://mma.prnewswire.com/media/2380040/Press_Release__2024_Kia_CEO_Investor_Day_240405.pdf

Cision View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/kia-presents-roadmap-to-lead-global-electrification-era-through-evs-hevs-and-pbvs-302109142.html

Continue Reading

Fintech PR

BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update

Published

on

biovaxys-technology-corp.-provides-bi-weekly-mcto-status-update

VANCOUVER, BC, April 4, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the “Company“) is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the “MCTO“), by its principal regulator, the Ontario Securities Commission (the “OSC“), under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“), following the Company’s announcement on February 21, 2024 (the “Default Announcement“), that it was unable to file its audited annual financial statements for the year ended October 31, 2023, its management’s discussion and analysis of financial statements for the year ended October 31, 2023, its annual information form for the year ended October 31, 2023, and related filings (collectively, the “Required Annual Filings“). Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.

As a result of the delay in filing the Required Annual Filings, the Company was unable to file its interim financial statements for the three months ended January 31, 2024, its management’s discussion and analysis of financial statements for the three months ended January 31, 2024, and related filings (collectively, the “Required Interim Filings“). Under National Instrument 51-102, the Required Interim Filings were required to be made no later than April 1, 2024.

The Company anticipates filing the Required Annual Filings by April 30, 2024. The auditor of the Company requires additional time to complete its audit of the Company, including the Company’s recent acquisition of all intellectual property, immunotherapeutics platform technologies, and clinical stage assets of the former IMV Inc. that closed on February 16, 2024. In addition, the Company anticipates filing the Required Interim Filings immediately after the filing of the Required Annual Filings.

Except as herein disclosed, there are no material changes to the information contained in the Default Announcement. In addition, (i) the Company is satisfying and confirms that it intends to continue to satisfy the provisions of the alternative information guidelines under NP 12-203 and issue bi-weekly default status reports for so long as the delay in filing the Required Annual Filings and/or Required Interim Filings is continuing, each of which will be issued in the form of a press release; (ii) the Company does not have any information at this time regarding any anticipated specified default subsequent to the default in filing the Required Annual Filings and Required Interim Filings; (iii) the Company is not subject to any insolvency proceedings; and (iv) there is no material information concerning the affairs of the Company that has not been generally disclosed.

About BioVaxys Technology Corp.

BioVaxys Technology Corp. (www.biovaxys.com), a biopharmaceuticals company registered in British Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and it’s HapTenix© ‘neoantigen’ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix© ‘neoantigen’ tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. The Company is also capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens. BioVaxys common shares are listed on the CSE under the stock symbol “BIOV” and trade on the Frankfurt Bourse (FRA: 5LB) and in the US (OTCQB: BVAXF). For more information, visit www.biovaxys.com and connect with us on X and LinkedIn.

ON BEHALF OF THE BOARD

Signed “James Passin
James Passin, Chief Executive Officer
Phone: +1 646 452 7054

Logo – https://mma.prnewswire.com/media/1430981/BIOVAXYS_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/biovaxys-technology-corp-provides-bi-weekly-mcto-status-update-302108920.html

Continue Reading

Trending